An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome

This narrative review reports on the pharmacological and pharmacokinetic properties of rotigotine, a non-ergolinic D(3)/D(2)/D(1) dopamine receptor agonist approved for the treatment of early- and advanced-stage Parkinson’s disease (PD) and moderate to severe restless legs syndrome (RLS). Rotigotine...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshoff, Jan-Peer, Cawello, Willi, Andreas, Jens-Otto, Mathy, Francois-Xavier, Braun, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382528/
https://www.ncbi.nlm.nih.gov/pubmed/25795100
http://dx.doi.org/10.1007/s40265-015-0377-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382528/
https://www.ncbi.nlm.nih.gov/pubmed/25795100
http://dx.doi.org/10.1007/s40265-015-0377-y

Ejemplares similares